SPS

Naloxone should be used with caution in patients with pre-existing cardiovascular disease or in those receiving potentially cardio-toxic drugs, since serious adverse cardiopulmonary effects (e.g., ventricular tachycardia and fibrillation, pulmonary edema, cardiac arrest) resulting in death, coma, and encephalopathy have occurred in ... ................
................